Live Webinar on "How to Invest successfully to reach goals without losing sleep" Sign up for Live Webinar
Did you know?
What made us buy IEX@193, Tata Power@56, Titan@330, Divis@629, Persistent@700.

Jeevan Scientific Technology informs about completion of USFDA audit

24 Jan 2020

Jeevan Scientific Technology has informed that USFDA conducted an un-announced audit of its Bioanalytical facility in Hyderabad. The purpose of this audit was to review the BA/BE studies conducted at its facilities. The auditors started the review on 20th January, 2020 and completed on 24th January, 2020 Audit concluded with ‘No Observations’ and Auditors are pleased with company procedures. This Audit is specifically to access and approve the bioequivalence studies conducted by JSTL for Pharmaceutical companies across the globe.

The above information is a part of company’s filings submitted to BSE.

Related Jeevan Scientific Technology Ltd. Links:

Jeevan Scientific Share Price

134.60 11.15 (9.03%) Nov 26, 18:01
1 Year Price Chart
Peers
Company Name CMP
TCS 3445.65
Infosys 1690.45
HCL Tech. 1107.75
Wipro 620.95
Tech Mahindra 1520.40
View more..
Sensex vs Jeevan Scientific
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback